Business Process Innovation and Cloud Computing

Business Process Management

Subscribe to Business Process Management: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Business Process Management: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

bpm Authors: Elizabeth White, Alan Williams, ManageEngine IT Matters, Wayne Salpietro, Astadia CloudGPS

News Feed Item

Development of Robust Clinical Decision Support Systems Key to Increased Adoption Across Europe

Development of Robust Clinical Decision Support Systems Key to Increased Adoption Across Europe

LONDON, August 23 /PRNewswire/ -- The development of robust clinical decision support systems (CDSS) will propel this nascent market into the growth stage. Rising concerns about patient safety will have a positive impact on market expansion, while increased confidence in the ability of clinical systems to improve healthcare delivery will support wider uptake.

Frost & Sullivan ( finds that the Clinical Decision Support Systems Markets in Europe earned revenue of $238.5 million in 2005 and estimates this to reach $430.7 million in 2012.

"With patient safety an issue of increasing concern across Europe, vendors must seek to create a strong relationship between clinical decision support (CDS) and enhanced patient safety", says Frost & Sullivan Research Analyst Kiran John. "Robust, scalable and proven CDSS systems will effectively address the demand for better patient safety."

Developing these robust systems will require extensive testing and product development. Over the next few years, CDS will experience a surge in terms of innovation and product development. CDSS providers are at the forefront of product development, and those who realise the need to offer high-performance CDSS will be best positioned to leverage emerging growth opportunities.

"Healthcare information technologies (HIT) vendors will have to formulate strategies to increase research on CDSS, and explore new avenues to creatively test CDSS solutions", observes Mr. John. "This dedication to research and development will ensure continued progress in terms of product accuracy and reliability."

However, low awareness levels among healthcare authorities is discouraging government funded research into CDSS. Hospital IT budgets are relatively inelastic to technological developments such as CDSS, and continue to restrain the HIT market as a whole.

"Continual product development and testing will be essential for ensuring greater accuracy, reliability, interoperability and scalability, and encouraging wider uptake", explains Mr John. "CDSS providers capable of delivering solutions with these attributes, stand to win lucrative contracts."

Currently, market participants include large firms offering enterprise solutions with CDS support as well as small-medium vendors, some of whom have single specialty offerings. While large HIT vendors granted IS contracts seek expertise from these specialty firms, small-medium sized specialty CDSS providers are, in turn, benefiting from these alliances in terms of improved visibility.

"Specialist participants already possess the expertise needed to carve distinct niches for themselves", elaborates Mr. John. "However, they will have to concentrate on building strategic alliances, in order to increase their visibility in the industry, as well as to have more effective access to decision makers."

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the Clinical Decision Support Systems Markets in Europe (B984 - 48) then send an e-mail to Radhika Menon Theodore - Corporate Communications at [email protected] with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

Clinical Decision Support System Markets in Europe is part of the Healthcare & Life Sciences IT Subscription, which also includes research in the following markets: European Hospital Administrative Systems Market, Competitive Profiles of Key Healthcare IT Firms and European Hospital Information Systems Markets. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit

Contact: Radhika Menon Theodore Corporate Communications - Europe P: +91-44-42044541 F: +91-44-24314264 E: [email protected] Melina Trevino Corporate Communications - Americas P: +1-210-247-2440 F: +1-210-348-1003 E: [email protected] Surbhi Dedhia Corporate Communications - India P: +91-22-5001-3431 E: [email protected] Jasminder Kaur Corporate Communications - Asia Pacific P: +65-68900937 E: [email protected] Sharmin Jassal Corporate Communications - Australia P: +61-2-8247-8900 F: +61-2-9252-8066 E: [email protected]://

Keywords in this release: clinical decision support systems, CDSS, clinical decision support, CDS, healthcare information technologies, HIT, CDSS solutions

Frost & Sullivan

CONTACT: Contact: Radhika Menon Theodore, Corporate Communications -
Europe, P: +91-44-42044541, F: +91-44-24314264, E: [email protected].
Melina Trevino, Corporate Communications - Americas, P: +1-210-247-2440, F:
+1-210-348-1003, E: [email protected]. Surbhi Dedhia, Corporate
Communications - India, P: +91-22-5001-3431, E: [email protected]. Jasminder
Kaur, Corporate Communications - Asia Pacific, P: +65-68900937, E:
[email protected]. Sharmin Jassal, Corporate Communications - Australia, P:
+61-2-8247-8900, F: +61-2-9252-8066, E: [email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.